drugset / Trial / NCT05244694

Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction

NCT05244694

Phase 0 Completed 28 enrolled University of Missouri-Columbia
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this project is to determine if hyperinsulinemia attenuates sympathetic nervous system-mediated vasoconstriction in the human leg.

Timeline

Start
2020-08-06
Primary completion
2021-06-25
Completion
2021-06-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 40 unknown

Indications

No indication recorded.